Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2)

 ESR2_RAT                Reviewed;         530 AA.
Q62986; O35784; O35785; O55015; O55016; O70195; Q9R185;
15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
15-JUL-1999, sequence version 2.
22-NOV-2017, entry version 169.
RecName: Full=Estrogen receptor beta;
Short=ER-beta;
AltName: Full=Nuclear receptor subfamily 3 group A member 2;
Name=Esr2; Synonyms=Erbeta, Nr3a2;
Rattus norvegicus (Rat).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Rattus.
NCBI_TaxID=10116;
[1]
NUCLEOTIDE SEQUENCE [MRNA] OF 46-530 (ISOFORM 1).
STRAIN=Sprague-Dawley; TISSUE=Prostate;
PubMed=8650195; DOI=10.1073/pnas.93.12.5925;
Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S.,
Gustafsson J.-A.;
"Cloning of a novel receptor expressed in rat prostate and ovary.";
Proc. Natl. Acad. Sci. U.S.A. 93:5925-5930(1996).
[2]
NUCLEOTIDE SEQUENCE [MRNA] OF 46-530 (ISOFORM 2).
STRAIN=Wistar; TISSUE=Ovary;
PubMed=9600083; DOI=10.1006/bbrc.1998.8590;
Maruyama K., Endoh H., Sasaki-Iwaoka H., Kanou H., Shimaya E.,
Hashimoto S., Kato S., Kawashima H.;
"A novel isoform of rat estrogen receptor beta with 18 amino acid
insertion in the ligand binding domain as a putative dominant negative
regular of estrogen action.";
Biochem. Biophys. Res. Commun. 246:142-147(1998).
[3]
NUCLEOTIDE SEQUENCE (ISOFORM 2).
STRAIN=Wistar; TISSUE=Prostate;
Aldridge T.C.;
"Tissue specific responses to estrogen: an explanation based on
differential activation of multiple estrogen receptors with different
estrogen response elements.";
Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE OF 46-530 (ISOFORMS 1; 3 AND 4).
STRAIN=Sprague-Dawley;
PubMed=9492041; DOI=10.1210/endo.139.3.5840;
Petersen D.N., Tkalcevic G.T., Koza-Taylor P.H., Turi T.G.,
Brown T.A.;
"Identification of estrogen receptor beta2, a functional variant of
estrogen receptor beta expressed in normal rat tissues.";
Endocrinology 139:1082-1092(1998).
[5]
PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 5).
STRAIN=Sprague-Dawley; TISSUE=Brain;
Price R., Handa R.J.;
"A novel splice variant of estrogen receptor beta found in rat
brain.";
Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
[6]
INTERACTION WITH UBE1C.
PubMed=11818503; DOI=10.1210/mend.16.2.0778;
Fan M., Long X., Bailey J.A., Reed C.A., Osborne E., Gize E.A.,
Kirk E.A., Bigsby R.M., Nephew K.P.;
"The activating enzyme of NEDD8 inhibits steroid receptor function.";
Mol. Endocrinol. 16:315-330(2002).
[7]
INTERACTION WITH DNAAF4.
PubMed=19423554; DOI=10.1093/hmg/ddp215;
Massinen S., Tammimies K., Tapia-Paez I., Matsson H., Hokkanen M.E.,
Soederberg O., Landegren U., Castren E., Gustafsson J.A., Treuter E.,
Kere J.;
"Functional interaction of DYX1C1 with estrogen receptors suggests
involvement of hormonal pathways in dyslexia.";
Hum. Mol. Genet. 18:2802-2812(2009).
-!- FUNCTION: Binds estrogens with an affinity similar to that of ER-
alpha, and activates expression of reporter genes containing
estrogen response elements (ERE) in an estrogen-dependent manner.
Isoform 3 and isoform 4 are unable to bind DNA and activate
transcription due to the truncation of the DNA binding domain.
Isoform 2 shows loss of ligand binding affinity and suppresses ER-
alpha and ER-beta1 mediated transcriptional activation and may act
as a dominant negative regulator of estrogen action.
-!- SUBUNIT: Binds DNA as a homodimer. Can form a heterodimer with
ESR1. Interacts with NCOA1, NCOA3, NCOA5 and NCOA6 coactivators,
leading to a strong increase of transcription of target genes.
Interacts with PELP1, UBE1C and AKAP13. Interacts with DNTTIP2 (By
similarity). Interacts with CCDC62 in the presence of
estradiol/E2; this interaction seems to enhance the transcription
of target genes. Interacts with PRMT2. Interacts with CCAR2 (via
N-terminus) in a ligand-independent manner (By similarity).
Interacts with DNAAF4. {ECO:0000250|UniProtKB:Q92731,
ECO:0000269|PubMed:11818503, ECO:0000269|PubMed:19423554}.
-!- INTERACTION:
P62989:Ubb; NbExp=2; IntAct=EBI-15938489, EBI-7038538;
-!- SUBCELLULAR LOCATION: Nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=5;
Comment=Additional isoforms seem to exist.;
Name=1; Synonyms=Beta1;
IsoId=Q62986-1; Sequence=Displayed;
Name=2; Synonyms=Beta2;
IsoId=Q62986-2; Sequence=VSP_003699;
Name=3; Synonyms=Beta1-delta3;
IsoId=Q62986-3; Sequence=VSP_003697;
Name=4; Synonyms=Beta2-delta3;
IsoId=Q62986-4; Sequence=VSP_003697, VSP_003699;
Name=5; Synonyms=Beta1-delta4;
IsoId=Q62986-5; Sequence=VSP_003698;
-!- TISSUE SPECIFICITY: Expressed in prostate, ovary, lung, liver,
kidney, fat, bone, brain, uterus and testis.
-!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
a DNA-binding domain and a C-terminal ligand-binding domain.
-!- PTM: Phosphorylation at Ser-87 and Ser-105 recruits NCOA1.
{ECO:0000250}.
-!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
subfamily. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=CAA05631.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U57439; AAC52602.1; -; mRNA.
EMBL; AB012721; BAA25431.1; -; mRNA.
EMBL; AJ002602; CAA05631.1; ALT_INIT; Genomic_DNA.
EMBL; AJ002603; CAA05632.1; -; Genomic_DNA.
EMBL; AF042058; AAB97424.1; -; mRNA.
EMBL; AF042059; AAB97425.1; -; mRNA.
EMBL; AF042060; AAB97426.1; -; mRNA.
EMBL; AF042061; AAB97427.1; -; mRNA.
EMBL; AF161187; AAD47637.1; -; mRNA.
PIR; JW0046; JW0046.
RefSeq; NP_036886.1; NM_012754.1.
UniGene; Rn.37460; -.
PDB; 1HJ1; X-ray; 2.30 A; A=255-509.
PDB; 1QKN; X-ray; 2.25 A; A=255-509.
PDB; 2J7X; X-ray; 2.10 A; A=255-509.
PDB; 2J7Y; X-ray; 1.80 A; A=255-509.
PDBsum; 1HJ1; -.
PDBsum; 1QKN; -.
PDBsum; 2J7X; -.
PDBsum; 2J7Y; -.
ProteinModelPortal; Q62986; -.
SMR; Q62986; -.
BioGrid; 247214; 6.
DIP; DIP-60383N; -.
IntAct; Q62986; 2.
STRING; 10116.ENSRNOP00000043144; -.
BindingDB; Q62986; -.
ChEMBL; CHEMBL3021; -.
GuidetoPHARMACOLOGY; 621; -.
PhosphoSitePlus; Q62986; -.
PaxDb; Q62986; -.
PRIDE; Q62986; -.
GeneID; 25149; -.
KEGG; rno:25149; -.
UCSC; RGD:2582; rat. [Q62986-1]
CTD; 2100; -.
RGD; 2582; Esr2.
eggNOG; KOG3575; Eukaryota.
eggNOG; ENOG410XRZC; LUCA.
HOVERGEN; HBG108344; -.
InParanoid; Q62986; -.
KO; K08551; -.
EvolutionaryTrace; Q62986; -.
PRO; PR:Q62986; -.
Proteomes; UP000002494; Unplaced.
GO; GO:0005929; C:cilium; IDA:RGD.
GO; GO:0005737; C:cytoplasm; IDA:RGD.
GO; GO:0005739; C:mitochondrion; IDA:MGI.
GO; GO:0043005; C:neuron projection; IDA:RGD.
GO; GO:0043025; C:neuronal cell body; IDA:RGD.
GO; GO:0005634; C:nucleus; IDA:RGD.
GO; GO:0043204; C:perikaryon; IDA:RGD.
GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
GO; GO:0005886; C:plasma membrane; IDA:RGD.
GO; GO:0032993; C:protein-DNA complex; IDA:RGD.
GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:RGD.
GO; GO:0003677; F:DNA binding; ISO:RGD.
GO; GO:0008144; F:drug binding; IPI:RGD.
GO; GO:0019899; F:enzyme binding; IPI:RGD.
GO; GO:1903924; F:estradiol binding; IPI:RGD.
GO; GO:0030284; F:estrogen receptor activity; IDA:RGD.
GO; GO:0034056; F:estrogen response element binding; IDA:RGD.
GO; GO:0042562; F:hormone binding; IDA:RGD.
GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:RGD.
GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
GO; GO:0038052; F:RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding; ISO:RGD.
GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
GO; GO:0005496; F:steroid binding; IDA:UniProtKB.
GO; GO:1990239; F:steroid hormone binding; IPI:RGD.
GO; GO:0003707; F:steroid hormone receptor activity; IDA:RGD.
GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
GO; GO:0021764; P:amygdala development; IEP:RGD.
GO; GO:0001662; P:behavioral fear response; IDA:RGD.
GO; GO:0007420; P:brain development; ISO:RGD.
GO; GO:0035690; P:cellular response to drug; IEP:RGD.
GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
GO; GO:0071259; P:cellular response to magnetism; IEP:RGD.
GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
GO; GO:0021549; P:cerebellum development; IEP:RGD.
GO; GO:0060743; P:epithelial cell maturation involved in prostate gland development; ISO:RGD.
GO; GO:0044849; P:estrous cycle; IMP:RGD.
GO; GO:0008585; P:female gonad development; IEP:RGD.
GO; GO:0008628; P:hormone-mediated apoptotic signaling pathway; ISO:RGD.
GO; GO:0021854; P:hypothalamus development; IEP:RGD.
GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; ISO:RGD.
GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IDA:RGD.
GO; GO:0007611; P:learning or memory; IMP:RGD.
GO; GO:0008584; P:male gonad development; IEP:RGD.
GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISO:RGD.
GO; GO:0048521; P:negative regulation of behavior; IDA:RGD.
GO; GO:0060548; P:negative regulation of cell death; IMP:RGD.
GO; GO:0008285; P:negative regulation of cell proliferation; ISO:RGD.
GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:RGD.
GO; GO:2000252; P:negative regulation of feeding behavior; IMP:RGD.
GO; GO:1901215; P:negative regulation of neuron death; IDA:RGD.
GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IMP:RGD.
GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:RGD.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:RGD.
GO; GO:0001764; P:neuron migration; ISO:RGD.
GO; GO:0001541; P:ovarian follicle development; IEP:RGD.
GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
GO; GO:0097755; P:positive regulation of blood vessel diameter; IMP:RGD.
GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IMP:RGD.
GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:RGD.
GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISS:UniProtKB.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:RGD.
GO; GO:0030850; P:prostate gland development; IEP:RGD.
GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
GO; GO:0042127; P:regulation of cell proliferation; ISO:RGD.
GO; GO:0043523; P:regulation of neuron apoptotic process; IDA:RGD.
GO; GO:0014823; P:response to activity; IEP:RGD.
GO; GO:1903925; P:response to bisphenol A; IEP:RGD.
GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
GO; GO:0042493; P:response to drug; IEP:RGD.
GO; GO:0032355; P:response to estradiol; IEP:RGD.
GO; GO:0043627; P:response to estrogen; IEP:RGD.
GO; GO:0045471; P:response to ethanol; IEP:RGD.
GO; GO:0033595; P:response to genistein; IEP:RGD.
GO; GO:0009725; P:response to hormone; IEP:RGD.
GO; GO:0044752; P:response to human chorionic gonadotropin; IEP:RGD.
GO; GO:0017085; P:response to insecticide; IEP:RGD.
GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
GO; GO:1902074; P:response to salt; IEP:RGD.
GO; GO:0033574; P:response to testosterone; IMP:RGD.
GO; GO:0009414; P:response to water deprivation; IEP:RGD.
GO; GO:0060009; P:Sertoli cell development; IEP:RGD.
GO; GO:0060011; P:Sertoli cell proliferation; IMP:RGD.
GO; GO:0060065; P:uterus development; ISO:RGD.
GO; GO:0060068; P:vagina development; ISO:RGD.
Gene3D; 1.10.565.10; -; 1.
Gene3D; 3.30.50.10; -; 1.
InterPro; IPR028355; ER-beta/gamma.
InterPro; IPR021064; Estrogen_rcpt_beta_N.
InterPro; IPR035500; NHR_like_dom_sf.
InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
InterPro; IPR001723; Nuclear_hrmn_rcpt.
InterPro; IPR024178; Oest_rcpt/oest-rel_rcp.
InterPro; IPR001628; Znf_hrmn_rcpt.
InterPro; IPR013088; Znf_NHR/GATA.
Pfam; PF12497; ERbeta_N; 1.
Pfam; PF00104; Hormone_recep; 1.
Pfam; PF00105; zf-C4; 1.
PIRSF; PIRSF500102; ER-b; 1.
PIRSF; PIRSF002527; ER-like_NR; 1.
PRINTS; PR00398; STRDHORMONER.
PRINTS; PR00047; STROIDFINGER.
SMART; SM00430; HOLI; 1.
SMART; SM00399; ZnF_C4; 1.
SUPFAM; SSF48508; SSF48508; 2.
PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
1: Evidence at protein level;
3D-structure; Activator; Alternative splicing; Complete proteome;
DNA-binding; Glycoprotein; Lipid-binding; Metal-binding; Nucleus;
Phosphoprotein; Receptor; Reference proteome; Steroid-binding;
Transcription; Transcription regulation; Zinc; Zinc-finger.
CHAIN 1 530 Estrogen receptor beta.
/FTId=PRO_0000053646.
DNA_BIND 149 214 Nuclear receptor. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
ZN_FING 149 169 NR C4-type. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
ZN_FING 185 209 NR C4-type. {ECO:0000255|PROSITE-
ProRule:PRU00407}.
REGION 1 148 Modulating.
REGION 215 530 Steroid-binding.
MOD_RES 61 61 Phosphoserine; alternate.
{ECO:0000250|UniProtKB:O08537}.
MOD_RES 87 87 Phosphoserine; by MAPK.
{ECO:0000250|UniProtKB:O08537}.
MOD_RES 105 105 Phosphoserine; by MAPK.
{ECO:0000250|UniProtKB:O08537}.
CARBOHYD 61 61 O-linked (GlcNAc) serine; alternate.
{ECO:0000250}.
VAR_SEQ 179 217 Missing (in isoform 3 and isoform 4).
{ECO:0000305}.
/FTId=VSP_003697.
VAR_SEQ 219 318 Missing (in isoform 5). {ECO:0000305}.
/FTId=VSP_003698.
VAR_SEQ 364 364 R -> RSSEDPHWHVAQMKSAAPR (in isoform 2
and isoform 4).
{ECO:0000303|PubMed:9600083}.
/FTId=VSP_003699.
CONFLICT 72 72 L -> Q (in Ref. 3 and 4). {ECO:0000305}.
CONFLICT 150 150 P -> A (in Ref. 3 and 4). {ECO:0000305}.
CONFLICT 165 165 S -> P (in Ref. 3; CAA05631).
{ECO:0000305}.
CONFLICT 505 505 S -> P (in Ref. 3; CAA05631).
{ECO:0000305}.
HELIX 265 274 {ECO:0000244|PDB:2J7Y}.
HELIX 291 315 {ECO:0000244|PDB:2J7Y}.
HELIX 319 321 {ECO:0000244|PDB:2J7Y}.
HELIX 324 347 {ECO:0000244|PDB:2J7Y}.
STRAND 353 357 {ECO:0000244|PDB:2J7Y}.
STRAND 360 363 {ECO:0000244|PDB:2J7Y}.
HELIX 364 369 {ECO:0000244|PDB:2J7Y}.
HELIX 373 390 {ECO:0000244|PDB:2J7Y}.
HELIX 394 405 {ECO:0000244|PDB:2J7Y}.
TURN 406 409 {ECO:0000244|PDB:2J7Y}.
HELIX 421 443 {ECO:0000244|PDB:2J7Y}.
HELIX 448 481 {ECO:0000244|PDB:2J7Y}.
HELIX 489 496 {ECO:0000244|PDB:2J7Y}.
SEQUENCE 530 AA; 59152 MW; 36F269D9FD773DA9 CRC64;
MEIKNSPSSL SSPASYNCSQ SILPLEHGPI YIPSSYVDNR HEYSAMTFYS PAVMNYSVPG
STSNLDGGPV RLSTSPNVLW PTSGHLSPLA THCQSSLLYA EPQKSPWCEA RSLEHTLPVN
RETLKRKLSG SSCASPVTSP NAKRDAHFCP VCSDYASGYH YGVWSCEGCK AFFKRSIQGH
NDYICPATNQ CTIDKNRRKS CQACRLRKCY EVGMVKCGSR RERCGYRIVR RQRSSSEQVH
CLSKAKRNGG HAPRVKELLL STLSPEQLVL TLLEAEPPNV LVSRPSMPFT EASMMMSLTK
LADKELVHMI GWAKKIPGFV ELSLLDQVRL LESCWMEVLM VGLMWRSIDH PGKLIFAPDL
VLDRDEGKCV EGILEIFDML LATTSRFREL KLQHKEYLCV KAMILLNSSM YPLASANQEA
ESSRKLTHLL NAVTDALVWV IAKSGISSQQ QSVRLANLLM LLSHVRHISN KGMEHLLSMK
CKNVVPVYDL LLEMLNAHTL RGYKSSISGS ECSSTEDSKN KESSQNLQSQ


Related products :

Catalog number Product name Quantity
EIAAB13284 ERR beta-2,ERRB2,ERR-beta,ESRL2,ESRRB,Estrogen receptor-like 2,Estrogen-related receptor beta,Homo sapiens,Human,NR3B2,Nuclear receptor subfamily 3 group B member 2,Steroid hormone receptor ERR2
EIAAB13286 Err2,ERR-beta,Esrl2,Esrrb,Estrogen receptor-like 2,Estrogen-related receptor beta,Nr3b2,Nuclear receptor subfamily 3 group B member 2,Rat,Rattus norvegicus,Steroid hormone receptor ERR2
EIAAB13285 Err2,Err-2,ERR-beta,Esrrb,Estrogen receptor-like 2,Estrogen-related receptor beta,Mouse,Mus musculus,Nr3b2,Nuclear receptor subfamily 3 group B member 2,Steroid hormone receptor ERR2
E2300p ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,Pig,Sus scrofa
E2300p ELISA ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,Pig,Sus scrofa 96T
U2300p CLIA kit ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,Pig,Sus scrofa 96T
E2300p ELISA kit ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,Pig,Sus scrofa 96T
E2300b Bos taurus,Bovine,ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2
U2300p CLIA ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2,Pig,Sus scrofa 96T
U2300b CLIA kit Bos taurus,Bovine,ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2 96T
U2300b CLIA Bos taurus,Bovine,ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2 96T
E2300r Erbeta,ER-beta,Esr2,Estrogen receptor beta,Nr3a2,Nuclear receptor subfamily 3 group A member 2,Rat,Rattus norvegicus
E2300m ER-beta,Esr2,Estrb,Estrogen receptor beta,Mouse,Mus musculus,Nr3a2,Nuclear receptor subfamily 3 group A member 2
E2300b ELISA kit Bos taurus,Bovine,ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2 96T
E2300b ELISA Bos taurus,Bovine,ER-beta,ESR2,Estrogen receptor beta,NR3A2,Nuclear receptor subfamily 3 group A member 2 96T
EIAAB35715 Homo sapiens,Human,NR1F2,Nuclear receptor ROR-beta,Nuclear receptor RZR-beta,Nuclear receptor subfamily 1 group F member 2,Retinoid-related orphan receptor-beta,RORB,RZRB
E2300h ER-beta,ESR2,ESTRB,Estrogen receptor beta,Homo sapiens,Human,NR3A2,Nuclear receptor subfamily 3 group A member 2
E2300r ELISA Erbeta,ER-beta,Esr2,Estrogen receptor beta,Nr3a2,Nuclear receptor subfamily 3 group A member 2,Rat,Rattus norvegicus 96T
U2300r CLIA kit Erbeta,ER-beta,Esr2,Estrogen receptor beta,Nr3a2,Nuclear receptor subfamily 3 group A member 2,Rat,Rattus norvegicus 96T
U2300m CLIA kit ER-beta,Esr2,Estrb,Estrogen receptor beta,Mouse,Mus musculus,Nr3a2,Nuclear receptor subfamily 3 group A member 2 96T
E2300m ELISA kit ER-beta,Esr2,Estrb,Estrogen receptor beta,Mouse,Mus musculus,Nr3a2,Nuclear receptor subfamily 3 group A member 2 96T
E2300r ELISA kit Erbeta,ER-beta,Esr2,Estrogen receptor beta,Nr3a2,Nuclear receptor subfamily 3 group A member 2,Rat,Rattus norvegicus 96T
U2300m CLIA ER-beta,Esr2,Estrb,Estrogen receptor beta,Mouse,Mus musculus,Nr3a2,Nuclear receptor subfamily 3 group A member 2 96T
E2300m ELISA ER-beta,Esr2,Estrb,Estrogen receptor beta,Mouse,Mus musculus,Nr3a2,Nuclear receptor subfamily 3 group A member 2 96T
U2300r CLIA Erbeta,ER-beta,Esr2,Estrogen receptor beta,Nr3a2,Nuclear receptor subfamily 3 group A member 2,Rat,Rattus norvegicus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur